Michel Fabbro
Université de Montpellier(FR)Cancer Institute (WIA)(IN)Arcagy Gineco(FR)Institut de Recherche en Cancérologie de Montpellier(FR)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, PARP inhibition in cancer therapy, Glioma Diagnosis and Treatment, BRCA gene mutations in cancer, Endometrial and Cervical Cancer Treatments
Most-Cited Works
- → Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer(2016)2,417 cited
- → Lomustine and Bevacizumab in Progressive Glioblastoma(2017)960 cited
- → Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial(2014)304 cited
- → Management and outcome of primary CNS lymphoma in the modern era(2020)233 cited
- → Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network(2016)194 cited
- → Sensitivity and resistance to treatment in the primary management of epithelial ovarian cancer(2013)191 cited